# OnCo record damora-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/damora-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "damora-therapeutics" ;
  schema:name "Damora Therapeutics"@en ;
  schema:description "Damora Therapeutics is developing antibody injections that target the faulty calreticulin protein that drives some blood cancers called myeloproliferative neoplasms, aiming to treat the cause of the disease rather than its symptoms."@en ;
  schema:url <https://onco.cc/companies/damora-therapeutics/>, <https://damoratx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://damoratx.com/>, <https://clinicaltrials.gov/study/NCT07849231> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/>, <https://onco.cc/cancers/essential-thrombocythaemia/>, <https://onco.cc/cancers/primary-myelofibrosis/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/calr/> .